Repligen Corporation Profile Avatar - Palmy Investing

Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding com…

Medical - Instruments & Supplies
US, Waltham [HQ]

Earnings Call Transcripts

Could not find a transcript
End of RGEN's Analysis
CIK: 730272 CUSIP: 759916109 ISIN: US7599161095 LEI: - UEI: -
Secondary Listings
RGEN has no secondary listings inside our databases.